USD 0.85
(6.99%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -3.14 USD | 48.36% |
2022 | -6.08 USD | -3140.0% |
2021 | 0.20 USD | 113.89% |
2020 | -1.44 USD | -48.45% |
2019 | -0.97 USD | -270.18% |
2018 | 0.57 USD | 106.12% |
2017 | -9.31 USD | 57.51% |
2016 | -21.91 USD | -2382.29% |
2015 | 0.96 USD | 26.32% |
2014 | 0.76 USD | 72.73% |
2013 | 0.44 USD | -45.68% |
2012 | 0.81 USD | 10.96% |
2011 | 0.73 USD | -74.39% |
2010 | 2.85 USD | 26.11% |
2009 | 2.26 USD | 111.83% |
2008 | -19.11 USD | -105.48% |
2007 | -9.30 USD | -4750.0% |
2006 | 0.20 USD | -44.44% |
2005 | 0.36 USD | -77.5% |
2004 | 1.60 USD | -23.08% |
2003 | 2.08 USD | 8.33% |
2002 | 1.92 USD | 236.84% |
2001 | 0.57 USD | -72.6% |
2000 | 2.08 USD | -25.71% |
1999 | 2.80 USD | 75.0% |
1998 | 1.60 USD | 11.11% |
1997 | 1.44 USD | 754.55% |
1996 | -0.22 USD | -4.76% |
1995 | -0.21 USD | 84.09% |
1994 | -1.32 USD | 44.77% |
1993 | -2.39 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.71 USD | -91.89% |
2024 Q1 | -0.37 USD | 48.61% |
2023 Q1 | -0.83 USD | 37.12% |
2023 Q4 | -0.72 USD | 18.18% |
2023 Q3 | -0.88 USD | -12.82% |
2023 Q2 | -0.78 USD | 6.02% |
2023 FY | - USD | 48.36% |
2022 Q2 | -0.59 USD | -654.48% |
2022 Q4 | -1.32 USD | -12.82% |
2022 FY | - USD | -3140.0% |
2022 Q1 | -0.08 USD | -119.55% |
2022 Q3 | -1.17 USD | -98.31% |
2021 Q4 | 0.40 USD | 534.92% |
2021 Q1 | 0.08 USD | 103.21% |
2021 Q3 | 0.06 USD | 133.16% |
2021 FY | - USD | 113.89% |
2021 Q2 | -0.19 USD | -346.75% |
2020 Q2 | -0.35 USD | 33.96% |
2020 FY | - USD | -48.45% |
2020 Q3 | 0.35 USD | 200.0% |
2020 Q1 | -0.53 USD | 90.5% |
2020 Q4 | -2.40 USD | -785.71% |
2019 FY | - USD | -270.18% |
2019 Q2 | -1.29 USD | -2454.46% |
2019 Q1 | -0.05 USD | 99.12% |
2019 Q4 | -5.58 USD | -465100.0% |
2019 Q3 | 0.00 USD | 100.09% |
2018 Q1 | 0.02 USD | 100.18% |
2018 Q3 | 0.04 USD | 53.57% |
2018 Q4 | -5.73 USD | -13425.58% |
2018 Q2 | 0.03 USD | 55.56% |
2018 FY | - USD | 106.12% |
2017 FY | - USD | 57.51% |
2017 Q2 | 0.04 USD | -26.79% |
2017 Q3 | 0.02 USD | -48.78% |
2017 Q4 | -10.14 USD | -48385.71% |
2017 Q1 | 0.06 USD | 100.25% |
2016 Q3 | -0.11 USD | -220.88% |
2016 FY | - USD | -2382.29% |
2016 Q2 | 0.09 USD | 131.38% |
2016 Q1 | -0.29 USD | -341.67% |
2016 Q4 | -22.16 USD | -20045.45% |
2015 Q1 | 0.17 USD | -5.56% |
2015 FY | - USD | 26.32% |
2015 Q3 | 0.53 USD | 341.67% |
2015 Q2 | 0.12 USD | -29.41% |
2015 Q4 | 0.12 USD | -77.36% |
2014 FY | - USD | 72.73% |
2014 Q1 | 0.20 USD | -4.76% |
2014 Q4 | 0.18 USD | -5.26% |
2014 Q3 | 0.19 USD | 0.0% |
2014 Q2 | 0.19 USD | -5.0% |
2013 Q4 | 0.21 USD | 132.81% |
2013 Q1 | 0.19 USD | -9.52% |
2013 FY | - USD | -45.68% |
2013 Q3 | -0.64 USD | -455.56% |
2013 Q2 | 0.18 USD | -5.26% |
2012 FY | - USD | 10.96% |
2012 Q4 | 0.21 USD | 0.0% |
2012 Q3 | 0.21 USD | -4.55% |
2012 Q2 | 0.22 USD | 15.79% |
2012 Q1 | 0.19 USD | 5.56% |
2011 Q4 | 0.18 USD | 0.0% |
2011 Q3 | 0.18 USD | -10.0% |
2011 Q1 | 0.18 USD | 20.0% |
2011 Q2 | 0.20 USD | 11.11% |
2011 FY | - USD | -74.39% |
2010 Q2 | 2.40 USD | 1500.0% |
2010 Q1 | 0.15 USD | 0.0% |
2010 Q3 | 0.14 USD | -94.17% |
2010 Q4 | 0.15 USD | 7.14% |
2010 FY | - USD | 26.11% |
2009 Q1 | 0.12 USD | 100.61% |
2009 FY | - USD | 111.83% |
2009 Q2 | 0.14 USD | 16.67% |
2009 Q3 | 0.15 USD | 7.14% |
2009 Q4 | 0.15 USD | 0.0% |
2008 Q2 | 0.29 USD | 31.82% |
2008 Q3 | 0.25 USD | -13.79% |
2008 Q4 | -19.57 USD | -7928.0% |
2008 FY | - USD | -105.48% |
2008 Q1 | 0.22 USD | -98.59% |
2007 Q3 | -7.93 USD | -5764.29% |
2007 Q4 | 15.61 USD | 296.85% |
2007 Q2 | 0.14 USD | -6.67% |
2007 Q1 | 0.15 USD | 50.0% |
2007 FY | - USD | -4750.0% |
2006 Q2 | -0.59 USD | -837.5% |
2006 Q1 | 0.08 USD | -38.46% |
2006 Q3 | 0.14 USD | 123.73% |
2006 Q4 | 0.10 USD | -28.57% |
2006 FY | - USD | -44.44% |
2005 Q3 | 0.10 USD | 33.33% |
2005 Q2 | 0.08 USD | -74.14% |
2005 Q1 | 0.29 USD | -51.67% |
2005 FY | - USD | -77.5% |
2005 Q4 | 0.13 USD | 30.0% |
2004 Q4 | 0.60 USD | 39.53% |
2004 Q1 | 0.21 USD | 162.5% |
2004 Q2 | 0.35 USD | 66.67% |
2004 Q3 | 0.43 USD | 22.86% |
2004 FY | - USD | -23.08% |
2003 Q3 | 0.66 USD | 0.0% |
2003 Q4 | 0.08 USD | -87.88% |
2003 Q1 | 0.66 USD | 22.22% |
2003 FY | - USD | 8.33% |
2003 Q2 | 0.66 USD | 0.0% |
2002 FY | - USD | 236.84% |
2002 Q2 | 0.45 USD | -6.25% |
2002 Q3 | 0.45 USD | 0.0% |
2002 Q1 | 0.48 USD | 172.73% |
2002 Q4 | 0.54 USD | 20.0% |
2001 FY | - USD | -72.6% |
2001 Q4 | -0.66 USD | -250.0% |
2001 Q3 | 0.44 USD | 37.5% |
2001 Q2 | 0.32 USD | -17.95% |
2001 Q1 | 0.39 USD | 24475.0% |
2000 Q2 | 0.64 USD | -20.0% |
2000 Q1 | 0.80 USD | 247.83% |
2000 Q3 | 0.80 USD | 25.0% |
2000 FY | - USD | -25.71% |
2000 Q4 | -0.00 USD | -100.2% |
1999 Q2 | 0.64 USD | 33.33% |
1999 Q4 | 0.23 USD | -64.06% |
1999 FY | - USD | 75.0% |
1999 Q1 | 0.48 USD | 242.86% |
1999 Q3 | 0.64 USD | 0.0% |
1998 Q2 | 0.32 USD | 0.0% |
1998 FY | - USD | 11.11% |
1998 Q3 | 0.48 USD | 50.0% |
1998 Q1 | 0.32 USD | 343.83% |
1998 Q4 | 0.14 USD | -70.83% |
1997 Q2 | 0.16 USD | 0.0% |
1997 Q3 | 0.32 USD | 100.0% |
1997 FY | - USD | 754.55% |
1997 Q4 | 0.07 USD | -77.47% |
1997 Q1 | 0.16 USD | 0.0% |
1996 Q1 | - USD | 100.0% |
1996 Q4 | - USD | -100.0% |
1996 Q3 | 0.16 USD | 0.0% |
1996 FY | - USD | -4.76% |
1996 Q2 | - USD | 0.0% |
1995 Q2 | -0.04 USD | 66.75% |
1995 Q3 | -0.04 USD | 0.0% |
1995 FY | - USD | 84.09% |
1995 Q4 | -0.08 USD | -96.24% |
1995 Q1 | -0.12 USD | 0.0% |
1994 Q3 | -0.77 USD | 0.0% |
1994 FY | - USD | 44.77% |
1994 Q2 | -0.77 USD | -57.14% |
1994 Q1 | -0.49 USD | 22.22% |
1993 Q4 | -0.63 USD | 0.0% |
1993 Q2 | -0.63 USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q3 | -0.63 USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aclaris Therapeutics, Inc. | -1.27 USD | -147.244% |
Biodesix, Inc. | -0.64 USD | -390.625% |
bioAffinity Technologies, Inc. | -0.91 USD | -245.055% |
Castle Biosciences, Inc. | -2.14 USD | -46.729% |
DarioHealth Corp. | -1.93 USD | -62.694% |
Exact Sciences Corporation | -1.13 USD | -177.876% |
IDEXX Laboratories, Inc. | 10.17 USD | 130.875% |
Illumina, Inc. | -7.35 USD | 57.279% |
Intelligent Bio Solutions Inc. | -6.38 USD | 50.784% |
iSpecimen Inc. | -1.23 USD | -155.285% |
Standard BioTools Inc. | -0.94 USD | -234.043% |
23andMe Holding Co. | -1.40 USD | -124.286% |
Medpace Holdings, Inc. | 9.20 USD | 134.13% |
NeoGenomics, Inc. | -0.70 USD | -348.571% |
Inotiv, Inc. | -4.10 USD | 23.415% |
Psychemedics Corporation | -0.72 USD | -336.111% |
Prenetics Global Limited | -5.58 USD | 43.728% |
Precipio, Inc. | -4.51 USD | 30.377% |
RadNet, Inc. | 0.05 USD | 6655.324% |
Sotera Health Company | 0.18 USD | 1844.444% |
Star Equity Holdings, Inc. | 7.42 USD | 142.318% |
Exagen Inc. | -1.34 USD | -134.328% |
Natera, Inc. | -3.78 USD | 16.931% |
Aspira Women's Health Inc. | -1.81 USD | -73.481% |
Neogen Corporation | -0.04 USD | -7118.391% |
Myriad Genetics, Inc. | -1.39 USD | -125.899% |
ICON Public Limited Company | 7.46 USD | 142.091% |
Bionano Genomics, Inc. | -6.81 USD | 53.891% |
CareDx, Inc | -3.54 USD | 11.299% |
Check-Cap Ltd. | -3.00 USD | -4.667% |
Twist Bioscience Corporation | -3.60 USD | 12.778% |
Guardant Health, Inc. | -4.28 USD | 26.636% |
BioNexus Gene Lab Corp. | -0.17 USD | -1747.059% |
Fulgent Genetics, Inc. | -5.63 USD | 44.227% |
Sera Prognostics, Inc. | -1.16 USD | -170.69% |
OPKO Health, Inc. | -0.25 USD | -1156.0% |
Personalis, Inc. | -2.25 USD | -39.556% |
Applied DNA Sciences, Inc. | -15.21 USD | 79.356% |
Star Equity Holdings, Inc. | 7.42 USD | 142.318% |
MDxHealth SA | -1.66 USD | -89.157% |
Prenetics Global Limited | -5.58 USD | 43.728% |
ENDRA Life Sciences Inc. | -1.11 USD | -182.883% |
Mainz Biomed B.V. | -1.62 USD | -93.827% |
Neuronetics, Inc. | -1.05 USD | -199.048% |
bioAffinity Technologies, Inc. | -0.91 USD | -245.055% |